Future research using a 2 × 2 factorial design with AD patients/HCs, with low/moderate depression scores may reveal whether DAT methylation is also elevated in HCs with BDI scores indicating moderate depression. This evidence concerns the gene SLC6A3 and depressive symptom measurement.